Brazil Health Regulator Sets Rules for COVID-19 Vaccine Emergency Use

The decision will potentially allow emergency use of vaccines that are being tested in Brazil by AstraZeneca, Pfizer Inc, Johnson & Johnson’s pharmaceutical subsidiary Janssen, and China’s Sinovac Biotech.

RIO DE JANEIRO, BRAZIL - Brazil’s health regulator Anvisa decided on Thursday to allow temporary emergency use authorizations for COVID-19 vaccines and set rules for companies to apply for the option that did not exist in the country.

The decision will potentially allow emergency use

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?